This is the authors' abstract. We don't add key points for this paper.
Background/Objectives: Brain functional homeostasis encompasses coordinated electrophysiological, neuroimmune, neurovascular–metabolic, and neuroplastic regulatory processes, which may become perturbed in neurological and psychiatric disorders. Transcutaneous auricular vagus nerve stimulation (taVNS) provides a non-invasive approach to modulate this system. However, the interactions among these regulatory processes and their relationships with taVNS have not yet been comprehensively synthesized. This review asks what taVNS changes within each dimension and how directly the measurements reflect the process they are taken to represent. Methods: We searched PubMed (28 August 2026) and performed a complementary Web of Science search on 3 November 2026 for taVNS studies published between January 2016 and August 2026, using free-text terms for taVNS and its variants. After duplicate removal and title/abstract screening, records were assigned to clinical-evidence, mechanism-supplement, and reviews/meta-analyses libraries. Studies were eligible if they used taVNS at an explicit auricular site, addressed efficacy or mechanism, included an effect comparison, and reported a central or clinically relevant readout. Results: Evidence is unevenly distributed. Electrophysiological effects, including modulation of excitation/inhibition balance and oscillatory activity, have been documented directly in humans; neuroimmune effects rest largely on animal work on the cholinergic anti-inflammatory pathway and α7 nicotinic acetylcholine receptor signaling; neurovascular and metabolic effects derive from a much smaller base; and neuroplastic effects are inferred mainly from molecular markers and imaging. Trials spanning major neurological, psychiatric, and perioperative indications report heterogeneous outcomes, and comparators are rarely physiologically inert. Conclusions: Existing taVNS findings can be organized into four domains of brain functional homeostasis, although coordinated regulation across these domains and its contribution to clinical benefit remain to be established. Further progress requires well-controlled trials, standardized reporting of stimulation parameters and comparator conditions, validation of response biomarkers, and prospective evaluation of event-triggered stimulation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: